Reference no: EM133445454

The patient is a 25-year-old single Caucasian female seeking further treatment for her anxiety and depression. After the patient's long-term relationship of eight years ended, she was diagnosed with generalized anxiety disorder and major depressive disorder at the age of 23. The patient has a history of persistent depressive symptoms, including an aversion to housework, an inability to relax, anhedonia, and self-care. 
The patient stopped eating and sleeping well, became increasingly agitated and exhausted, and ate less. Mood swings are something the patient struggles with occasionally. At her previous appointment, she was prescribed Buspirone. 
During this visit, she claimed she had not experienced any adverse effects. The patient reports sleeping well and having a normal appetite during this visit. She rates her depression at 4/10 and her anxiety at 2/10. 
The patient insists she is not experiencing any hostile emotions. 
The patient denies having hallucinations, psychotic symptoms, or thoughts of harming herself or others. The patient is in a committed relationship at this time.

Current psychiatric medications: 

• Sertraline 50 mg tablet by mouth daily for depression.
• Buspirone 7.5mg  tablet by mouth daily for anxiety
• Is informing my patient's partner about her clinical status ethically right?

Current medications are working well, with no side effects reported.

1. Does the patient need close monitoring of her improvement of depression? If yes, why?
2. Is the patient at risk of suicide, even with her denial of suicidal ideation?